BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16290986)

  • 41. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy.
    Wöhrle J; Krause BJ; Nusser T; Kochs M; Höher M
    Cardiovasc Revasc Med; 2006; 7(1):2-6. PubMed ID: 16513516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis.
    Lau HK; Segev A; Hegele RA; Sparkes JD; Teitel JM; Chisholm RJ; Strauss BH
    Thromb Haemost; 2003 Dec; 90(6):1187-91. PubMed ID: 14652655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation.
    Tutar E; Ozcan M; Kilickap M; Gülec S; Aras O; Pamir G; Oral D; Dandelet L; Key NS
    Circulation; 2003 Sep; 108(13):1581-4. PubMed ID: 12975255
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins.
    Hoshida S; Nishino M; Takeda T; Tanouchi J; Yamada Y; Hori M
    Atherosclerosis; 2004 Apr; 173(2):285-90. PubMed ID: 15064103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients.
    West NE; Ruygrok PN; Disco CM; Webster MW; Lindeboom WK; O'Neill WW; Mercado NF; Serruys PW
    Circulation; 2004 Feb; 109(7):867-73. PubMed ID: 14757691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Binary restenosis post-cutting balloon ptca before stenting].
    Flores JF; Villada JA; Ruiz EB; Hernández JS; Silvestre AM; Sandoval RA; Gallegos JE; Velasco AA; Campa JF
    Arch Cardiol Mex; 2006; 76(4):408-14. PubMed ID: 17315618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
    Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
    J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of a centered 32P source wire system with a noncentered 90Sr/Y brachytherapy system for intracoronary beta-radiation following PCI of diffuse in-stent restenosis.
    Haase J; von Neumann-Cosel P; Damm M; Hofmann M; Störger H; Isner D; Bergmann M; Piancatelli C; Schächinger V; Schwarz F
    Cardiovasc Revasc Med; 2005; 6(4):140-6. PubMed ID: 16326374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lesion regression after percutaneous coronary intervention for unprotected left main trunk disease.
    Kosuga K; Tamai H; Kyo E; Hata T; Okada M; Nakamura T; Fujita S; Tsuji T; Takeda S; Inuzuka Y; Motohara S; Uehata H
    Int J Cardiovasc Intervent; 2003; 5(3):132-6. PubMed ID: 12959729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis.
    Naruko T; Ueda M; Ehara S; Itoh A; Haze K; Shirai N; Ikura Y; Ohsawa M; Itabe H; Kobayashi Y; Yamagishi H; Yoshiyama M; Yoshikawa J; Becker AE
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):877-83. PubMed ID: 16469945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An important role for VCAM-1, but not for ICAM-1 in restenosis following coronary stent implantation.
    Bayata S; Arıkan E; Yeşil M; Postacı N; Taş A; Köseoğlu M
    Anadolu Kardiyol Derg; 2010 Oct; 10(5):405-9. PubMed ID: 20929696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized trial of conventional balloon angioplasty versus cutting balloon for in-stent restenosis. Acute and 24-hour angiographic and intravascular ultrasound changes and long-term follow-up.
    Montorsi P; Galli S; Fabbiocchi F; Trabattoni D; Ravagnani PM; Bartorelli AL
    Ital Heart J; 2004 Apr; 5(4):271-9. PubMed ID: 15185885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modifications of minimal luminal diameter during the 24 hours following percutaneous treatment of in-stent restenosis.
    Rubartelli P; Giachero C; Abbadessa F; Vischi M; Chierchia S
    J Invasive Cardiol; 2004 Oct; 16(10):575-7. PubMed ID: 15505354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
    Serruys PW; de Jaegere P; Kiemeneij F; Macaya C; Rutsch W; Heyndrickx G; Emanuelsson H; Marco J; Legrand V; Materne P
    N Engl J Med; 1994 Aug; 331(8):489-95. PubMed ID: 8041413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina.
    Mito T; Miura S; Iwata A; Morii J; Sugihara M; Ike A; Mori K; Kawamura A; Nishikawa H; Zhang B; Saku K
    Coron Artery Dis; 2011 Nov; 22(7):451-7. PubMed ID: 21811155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
    Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
    Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
    Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
    J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
    Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
    EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry.
    Jensen JK; Jensen LO; Terkelsen CJ; Lassen JF; Tilsted HH; Hansen KN; Maeng M; Thuesen L; Thayssen P
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):260-5. PubMed ID: 22511512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis.
    L'Allier PL; Tardif JC; Grégoire J; Joyal M; Lespérance J; Fortier A; Guertin MC
    Can J Cardiol; 2005 May; 21(6):495-500. PubMed ID: 15917878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.